- Home
- KSS vs KNSA Comparison
KSS vs KNSA Comparison
Compare KSS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KSS
- KNSA
- Stock Information
- Founded
- KSS 1962
- KNSA 2015
- Country
- KSS United States
- KNSA United Kingdom
- Employees
- KSS N/A
- KNSA N/A
- Industry
- KSS Department/Specialty Retail Stores
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- KSS Consumer Discretionary
- KNSA Health Care
- Exchange
- KSS Nasdaq
- KNSA Nasdaq
- Market Cap
- KSS 1.4B
- KNSA 1.5B
- IPO Year
- KSS 1992
- KNSA 2018
- Fundamental
- Price
- KSS $6.48
- KNSA $20.21
- Analyst Decision
- KSS Sell
- KNSA Strong Buy
- Analyst Count
- KSS 12
- KNSA 6
- Target Price
- KSS $10.57
- KNSA $37.17
- AVG Volume (30 Days)
- KSS 14.2M
- KNSA 638.0K
- Earning Date
- KSS 05-29-2025
- KNSA 04-29-2025
- Dividend Yield
- KSS 25.04%
- KNSA N/A
- EPS Growth
- KSS N/A
- KNSA N/A
- EPS
- KSS 0.98
- KNSA N/A
- Revenue
- KSS $16,221,000,000.00
- KNSA $423,239,000.00
- Revenue This Year
- KSS N/A
- KNSA $37.21
- Revenue Next Year
- KSS N/A
- KNSA $2.58
- P/E Ratio
- KSS $6.61
- KNSA N/A
- Revenue Growth
- KSS N/A
- KNSA 56.60
- 52 Week Low
- KSS $6.04
- KNSA $16.56
- 52 Week High
- KSS $28.25
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- KSS 37.96
- KNSA 44.56
- Support Level
- KSS $6.04
- KNSA $18.26
- Resistance Level
- KSS $6.96
- KNSA $21.24
- Average True Range (ATR)
- KSS 0.76
- KNSA 1.12
- MACD
- KSS 0.00
- KNSA -0.12
- Stochastic Oscillator
- KSS 16.67
- KNSA 44.43
About KSS Kohl's Corporation
Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.